As discussed in the last Pharmacy Pearls “Less Expensive Inhaler Now Available,” switching patients to RespiClick will help AHP realize significant savings as well as help patients with their out-of-pocket costs. The patient education handout below can be provided to patients making the switch to ensure that they use their new inhaler correctly.
135 Corporate Woods, Suite 320
Rochester, New York 14623-1466
Phone: (585) 758-7823
Fax: (585) 424-1268
© Copyright - Accountable Health Partners - 2025
Website by: 
This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP). An offer will only be made by means of a confidential private placement memorandum and subscription agreement.
| ABI Value | Interpretation | Recommendation |
|---|---|---|
| Greater than 1.4 | Calcification/vessel hardening | Refer to vascular specialist |
| 1.0 - 1.4 | Normal | None |
| 0.9 - 1.0 | Acceptable | None |
| 0.8 - 0.9 | Some arterial disease | Treat risk factor |
| 0.5 - 0.8 | Moderate arterial disease | Refer to vascular specialist |
| Less than 0.5 | Severe arterial disease | Refer to vascular specialist |
